Metabolic biomarkers significantly enhance the prediction of HBV-related ACLF occurrence and outcomes
- 28 July 2023
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 79 (5) , 1159-1171
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Acute-on-chronic liver failureThe Lancet, 2015
- Adrenal insufficiency in patients with decompensated cirrhosisWorld Journal of Hepatology, 2015
- Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failureJournal of Hepatology, 2014
- Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of CirrhosisGastroenterology, 2013
- Fatty acid omega‐oxidation as a rescue pathway for fatty acid oxidation disorders in humansThe FEBS Journal, 2010
- The brain glutamate system in liver failureJournal of Neurochemistry, 2006
- NAAG peptidase inhibitors and their potential for diagnosis and therapyNature Reviews Drug Discovery, 2005
- Hyperpipecolic acidaemia: a diagnostic tool for peroxisomal disordersMolecular Genetics and Metabolism, 2004
- Plasma levels of pipecolic acid in patients with chronic liver diseaseHepatology, 1988
- Serum bile acids in liver diseaseGut, 1971